A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
about
KASL clinical practice guidelines: management of hepatitis CMany hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Hepatitis C transmission and treatment in contact networks of people who inject drugs.Molecular and contextual markers of hepatitis C virus and drug abuse.Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionSpontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisHepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyFrequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfectionHepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review.Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.HCV reinfection incidence among individuals treated for recent infection.KASL clinical practice guidelines: management of hepatitis C.
P2860
Q26752471-9E2EC7B7-AEFB-4D5E-8783-D4DFBF20F900Q30884457-4962669E-BB88-401D-9788-5C2BAD67DE45Q33687240-C804AF54-1736-4CAD-82F0-4A0E8EA22C50Q33824723-29222640-FB65-4819-8387-868C4437ED6EQ35040866-6C41379C-F974-4E4D-800A-590834B82CEAQ35660841-0615A247-971D-47AF-B562-216583A0B7F5Q35846408-AF4A5CF5-5D70-46B9-9394-1ECD02184FF3Q36123263-0D970034-F593-4730-A840-90FDC90D78FEQ36148971-ECAC7DEF-AFDE-4D7C-9F52-385BBD46A91AQ36517794-8794F80B-6A3D-4F21-8983-BA9E5661AB74Q36717008-D955768E-5B42-413B-A8ED-FB052C517F9BQ37288631-F4D17C97-D222-422D-95EB-DE1D65044C71Q38050834-F0335C04-1E80-48C7-8D97-EF60AC7D7E91Q38123948-4B222AD4-9F85-462C-8DA6-77ED7E5A3B2CQ38381584-6F1030E3-E9F8-43FC-9E27-22F03D6666D0Q38407675-25D0A3BB-8C72-49FB-8AC2-8F66C08116CAQ38692113-5774A671-B2A4-4C82-930E-62FE4730458BQ40037737-94A78202-9BEB-4033-A2AD-D942F236A120Q40393982-4A2BC5F0-567A-45D8-B95F-FC84628656C4Q51836024-ABB70A0C-9DD3-41B9-807A-6A2436BDA777
P2860
A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A prospective study to examine ...... previously cleared the virus.
@en
A prospective study to examine ...... previously cleared the virus.
@nl
type
label
A prospective study to examine ...... previously cleared the virus.
@en
A prospective study to examine ...... previously cleared the virus.
@nl
prefLabel
A prospective study to examine ...... previously cleared the virus.
@en
A prospective study to examine ...... previously cleared the virus.
@nl
P2093
P1476
A prospective study to examine ...... previously cleared the virus.
@en
P2093
Alexander Monto
Daniel Tracy
James C Ryan
Michael Kim
Rosemary McQuaid
Sally George
Sue L Currie
Teresa L Wright
P304
P356
10.1016/J.DRUGALCDEP.2007.09.011
P577
2007-10-30T00:00:00Z